keyword
https://read.qxmd.com/read/38650723/predicting-anxiety-depression-and-insomnia-among-bangladeshi-university-students-using-tree-based-machine-learning-models
#1
JOURNAL ARTICLE
Arman Hossain Chowdhury, Dana Rad, Md Siddikur Rahman
BACKGROUND AND AIMS: Mental health problem is a rising public health concern. People of all ages, specially Bangladeshi university students, are more affected by this burden. Thus, the objective of the study was to use tree-based machine learning (ML) models to identify major risk factors and predict anxiety, depression, and insomnia in university students. METHODS: A social media-based cross-sectional survey was employed for data collection. We used Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ-9) and Insomnia Severity Index (ISI-7) scale for measuring students' anxiety, depression and insomnia problems...
April 2024: Health Science Reports
https://read.qxmd.com/read/38650657/b-cells-and-the-stressed-brain-emerging-evidence-of-neuroimmune-interactions-in-the-context-of-psychosocial-stress-and-major-depression
#2
REVIEW
Elizabeth Engler-Chiurazzi
The immune system has emerged as a key regulator of central nervous system (CNS) function in health and in disease. Importantly, improved understanding of immune contributions to mood disorders has provided novel opportunities for the treatment of debilitating stress-related mental health conditions such as major depressive disorder (MDD). Yet, the impact to, and involvement of, B lymphocytes in the response to stress is not well-understood, leaving a fundamental gap in our knowledge underlying the immune theory of depression...
2024: Frontiers in Cellular Neuroscience
https://read.qxmd.com/read/38649428/efficacy-and-safety-of-aticaprant-a-kappa-receptor-antagonist-adjunctive-to-oral-ssri-snri-antidepressant-in-major-depressive-disorder-results-of-a-phase-2-randomized-double-blind-placebo-controlled-study
#3
JOURNAL ARTICLE
Mark E Schmidt, Iva Kezic, Vanina Popova, Rama Melkote, Peter Van Der Ark, Darrel J Pemberton, Guy Mareels, Carla M Canuso, Maurizio Fava, Wayne C Drevets
This was a double-blind, randomized, phase 2 study of adults (18-64 years) with DSM-5 diagnosis of major depressive disorder (MDD), with moderate-to-severe episode severity (Montgomery-Åsberg Depression Rating Scale [MADRS] ≥25) despite an adequate course with ongoing antidepressant for ≥6 weeks to ≤12 months. Following a double-blind placebo lead-in period (up to 3 weeks), participants were randomized to receive once daily aticaprant 10 mg or continue placebo, added to their ongoing treatment, for 6 weeks...
April 22, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38647077/anxiety-depression-and-quality-of-life-in-patients-with-head-and-neck-cancer-undergoing-laryngectomy-a-long-term-prospective-evaluation
#4
JOURNAL ARTICLE
Nobuaki Mukoyama, Naoki Nishio, Hiroyuki Kimura, Tatsuya Tokura, Shinichi Kishi, Kazuyoshi Ogasawara, Hidenori Tsuzuki, Sayaka Yokoi, Akihisa Wada, Mayu Shigeyama, Norio Ozaki, Yasushi Fujimoto, Michihiko Sone
BACKGROUND: This study aimed to assess anxiety, depression and quality of life (QoL) in patients with head and neck cancer undergoing laryngectomy using comprehensive self-reported questionnaires for a period of up to 5 years. METHODS: This prospective observational study enrolled 150 consecutive patients with locally advanced head and neck cancer who underwent laryngectomy at Nagoya University Hospital between 2007 and 2020. Anxiety, depression and QoL were assessed at baseline (preoperative) and at 3, 6, 12, 24, 36, 48 and 60 months after surgery using two brief self-reported questionnaires, such as the eight-item Short Form Health Survey (SF-8) and the Hospital Anxiety and Depression Scale (HADS)...
April 22, 2024: International Journal of Language & Communication Disorders
https://read.qxmd.com/read/38645414/temporal-binding-and-sense-of-agency-in-major-depression
#5
JOURNAL ARTICLE
David H V Vogel, Mathis Jording, Peter H Weiss, Kai Vogeley
BACKGROUND: Alterations in the experience of controlling oneself and one's environment are of high relevance to understanding the psychopathology of depression. This study investigated the relationship between Temporal Binding for action-event sequences, sense of agency, self-efficacy and symptom severity in Major Depressive Disorder. METHOD: We employed the Sense of Agency Scale (SoAS) and the General Self-Efficacy Scale (GSE) to assess explicit Sense of Agency and self-efficacy in a group of 42 persons diagnosed with Major Depressive Disorder (MDD) [20 identifying as female, 19 as male; mean age 37...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38645124/optimizing-antidepressant-efficacy-multimodal-neuroimaging-biomarkers-for-prediction-of-treatment-response
#6
Xiaoyu Tong, Kanhao Zhao, Gregory A Fonzo, Hua Xie, Nancy B Carlisle, Corey J Keller, Desmond J Oathes, Yvette Sheline, Charles B Nemeroff, Leanne M Williams, Madhukar Trivedi, Amit Etkin, Yu Zhang
UNLABELLED: Major depressive disorder (MDD) is a common and often severe condition that profoundly diminishes quality of life for individuals across ages and demographic groups. Unfortunately, current antidepressant and psychotherapeutic treatments exhibit limited efficacy and unsatisfactory response rates in a substantial number of patients. The development of effective therapies for MDD is hindered by the insufficiently understood heterogeneity within the disorder and its elusive underlying mechanisms...
April 12, 2024: medRxiv
https://read.qxmd.com/read/38642505/valuing-the-health-benefits-of-nature-based-recreational-physical-activity-in-england
#7
JOURNAL ARTICLE
James Grellier, Mathew P White, Siân de Bell, Oscar Brousse, Lewis R Elliott, Lora E Fleming, Clare Heaviside, Charles Simpson, Tim Taylor, Benedict W Wheeler, Rebecca Lovell
Physical activity (PA) reduces the risk of several non-communicable diseases (NCDs). Natural environments support recreational PA. Using data including a representative cross-sectional survey of the English population, we estimated the annual value of nature-based PA conducted in England in 2019 in terms of avoided healthcare and societal costs of disease. Population-representative data from the Monitor of Engagement with the Natural Environment (MENE) survey (n = 47,580; representing 44,386,756) were used to estimate the weekly volume of nature-based recreational PA by adults in England in 2019...
April 16, 2024: Environment International
https://read.qxmd.com/read/38642087/long-term-effects-on-swallowing-and-laryngeal-function-after-treatment-for-severe-covid-19-disease-in-intensive-care
#8
JOURNAL ARTICLE
Hans Dotevall, Lisa Tuomi, Ellen Lindell, Caterina Finizia
PURPOSE: This study aimed to assess swallowing and laryngeal function at long-term follow-up in patients treated for severe COVID-19 in the ICU. METHODS: Thirty-six patients with severe COVID-19 were prospectively examined with fiberendoscopic evaluation of swallowing (FEES) about 6 and 12 months after ICU discharge. Comparison with initial FEES examinations during the time in hospital was performed in 17 patients. Analysis of swallowing function and laryngeal features was performed from video recordings...
April 20, 2024: European Archives of Oto-rhino-laryngology
https://read.qxmd.com/read/38640975/brain-stimulation-over-the-left-dlpfc-enhances-motivation-for-effortful-rewards-in-patients-with-major-depressive-disorder
#9
JOURNAL ARTICLE
Rong Bi, Yanli Zhao, Sijin Li, Feng Xu, Weiwei Peng, Shuping Tan, Dandan Zhang
BACKGROUND: Amotivation is a typical feature in major depressive disorder (MDD), which produces reduced willingness to exert effort. The dorsolateral prefrontal cortex (DLPFC) is a crucial structure in goal-directed actions and therefore is a potential target in modulating effortful motivation. However, it remains unclear whether the intervention is effective for patients with MDD. METHODS: We employed transcranial magnetic stimulation (TMS), computational modelling and event-related potentials (ERPs) to reveal the causal relationship between the left DLPFC and motivation for effortful rewards in MDD...
April 17, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38640589/auditory-p50-sensory-gating-alterations-in-major-depressive-disorder-and-their-relationship-to-clinical-symptoms
#10
JOURNAL ARTICLE
Sara de la Salle, Hayley Bowers, Meagan Birmingham, Jennifer L Phillips, Pierre Blier, Verner Knott
Cognitive deficits in depression are pervasive and include impairments in attention and higher-order functions but the degree to which low-level sensory processes are affected is unclear. The present work examined event-related potential (P50 and N100) features of auditory sensory gating (i.e., the ability to inhibit P50/N100 responses to redundant stimuli) and their relationship to depressive symptoms, including ruminations and dysfunctional attitudes. In 18 patients with major depressive disorder (MDD) and 18 healthy volunteers, auditory sensory gating was measured using a paired-stimulus paradigm yielding ratio (rP50, rN100) and difference (dP50, dN100) gating indices, which reflected amplitude reductions from first (S1) to second (S2) stimulus...
April 2, 2024: Psychiatry Research. Neuroimaging
https://read.qxmd.com/read/38640020/trends-in-incidence-of-hospitalization-for-hypoglycemia-and-diabetic-ketoacidosis-in-individuals-with-type-1-or-type-2-diabetes-with-and-without-severe-mental-illness-in-denmark-from-1996-to-2020-a-nationwide-study
#11
JOURNAL ARTICLE
Stine H Scheuer, Gregers S Andersen, Bendix Carstensen, Lars Diaz, Vanja Kosjerina, Nanna Lindekilde, Sarah H Wild, Caroline A Jackson, Frans Pouwer, Michael E Benros, Marit E Jørgensen
OBJECTIVE: To examine trends in incidence of acute diabetes complications in individuals with type 1 or type 2 diabetes with and without severe mental illness (SMI) in Denmark by age and calendar year. RESEARCH DESIGN AND METHODS: We conducted a cohort study using nationwide registers from 1996 to 2020 to identify individuals with diabetes, ascertain SMI status (namely, schizophrenia, bipolar disorder, or major depression) and identify the outcomes: hospitalization for hypoglycemia and diabetic ketoacidosis (DKA)...
April 19, 2024: Diabetes Care
https://read.qxmd.com/read/38639338/how-much-or-how-often-examining-the-screening-properties-of-the-dsm-cross-cutting-symptom-measure-in-a-youth-population-based-sample
#12
JOURNAL ARTICLE
João Pedro Gonçalves Pacheco, Christian Kieling, Pedro H Manfro, Ana M B Menezes, Helen Gonçalves, Isabel O Oliveira, Fernando C Wehrmeister, Luis Augusto Rohde, Maurício Scopel Hoffmann
BACKGROUND: The DSM Level 1 Cross-Cutting Symptom Measure (DSM-XC) allows for assessing multiple psychopathological domains. However, its capability to screen for mental disorders in a population-based sample and the impact of adverbial framings (intensity and frequency) on its performance are unknown. METHODS: The study was based on cross-sectional data from the 1993 Pelotas birth cohort in Brazil. Participants with completed DSM-XC and structured diagnostic interviews ( n = 3578, aged 22, 53...
April 19, 2024: Psychological Medicine
https://read.qxmd.com/read/38637747/comparing-attitudes-towards-compulsory-interventions-in-severe-and-persistent-mental-illness-among-psychiatrists-in-india-and-switzerland
#13
JOURNAL ARTICLE
Christina Rickli, Julia Stoll, Anna Lisa Westermair, Manuel Trachsel
BACKGROUND: Psychiatrists face a major ethical challenge when deciding whether to make use of coercive measures in the treatment process of patients suffering from severe and persistent mental illness (SPMI). As India and Switzerland show major cultural, political and financial differences, it is hypothesized that attitudes towards coercive measures among Indian and Swiss psychiatrists will vary too. Exploring differences in attitudes between cultures strengthens the critical reflection on one's own stances and in consequence, on our way of action...
April 18, 2024: BMC Psychiatry
https://read.qxmd.com/read/38636214/hypersomnolence-is-associated-with-non-remission-of-major-depressive-disorder
#14
JOURNAL ARTICLE
Maxine Ming Sum Cheung, Siu Ping Lam, Steven Wai Ho Chau, Ngan Yin Chan, Tim Mh Li, Yun Kwok Wing, Joey W Y Chan
OBJECTIVE: This study aimed to investigate the prevalence, clinical correlates and the relationship between hypersomnolence and clinical outcomes in a cohort of MDD patients. METHODS: This is a cross-sectional study of a MDD cohort in an university-affiliated adult psychiatric outpatient clinic. The diagnosis of MDD and severity of depression were ascertained by the clinician with structured clinical interviews. Each participant completed the Epworth Sleepiness Scale (ESS), 1-week sleep diary, and a battery of questionnaires that assessed usual sleep pattern, insomnia, anxiety, depression, fatigue and circadian preference...
April 16, 2024: Sleep Medicine
https://read.qxmd.com/read/38636108/evaluating-the-prevalence-and-risk-factors-for-depression-in-patients-with-temporal-lobe-epilepsy-with-hippocampal-sclerosis-a-cross-sectional-multicenter-study
#15
JOURNAL ARTICLE
Bandar N Aljafen, Ruwa Alneseyan, Taim Muayqil, Mashael O Alkhateeb, Mubarak M Aldosari, Aya Alsermani, Lujain Alnakhli, Renad Althomali, Razan Alnami, Ruba Alqahtani, Lama Ibrahim, Fawzi Babtain
BACKGROUND: Epilepsy frequently accompanies Major Depressive Disorder (MDD). Notably, people with temporal lobe epilepsy and hippocampal sclerosis may face an increased susceptibility to MDD, as evidence indicates the involvement of the limbic system in the development of emotional symptoms. OBJECTIVES: To determine the prevalence and predictors of depression in temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) and compare them to those of other epilepsy types...
April 17, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38633777/metabolomics-signatures-of-serotonin-reuptake-inhibitor-escitalopram-serotonin-norepinephrine-reuptake-inhibitor-duloxetine-and-cognitive-behavior-therapy-on-key-neurotransmitter-pathways-in-major-depressive-disorder
#16
Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, Marina Belenky, Vasant R Marur, A John Rush, W Edward Craighead, Helen S Mayberg, Boadie W Dunlop, Bruce S Kristal, Rima Kaddurah-Daouk
Metabolomics provides powerful tools that can inform about heterogeneity in disease and response to treatments. In this study, we employed an electrochemistry-based targeted metabolomics platform to assess the metabolic effects of three randomly-assigned treatments: escitalopram, duloxetine, and Cognitive Behavior Therapy (CBT) in 163 treatment-naïve outpatients with major depressive disorder. Serum samples from baseline and 12 weeks post-treatment were analyzed using targeted liquid chromatography-electrochemistry for metabolites related to tryptophan, tyrosine metabolism and related pathways...
April 3, 2024: medRxiv
https://read.qxmd.com/read/38632556/study-protocol-exercise-training-for-treating-major-depressive-disorder-in-multiple-sclerosis
#17
JOURNAL ARTICLE
Robert W Motl, Charles H Bombardier, Jennifer Duffecy, Brooks Hibner, Alison Wathen, Michael Carrithers, Gary Cutter
BACKGROUND: Major depressive disorder (MDD) is prevalent, yet sub-optimally treated among persons with multiple sclerosis (MS). We propose that exercise training may be a promising approach for treating depression in persons with MS who have MDD. Our primary hypothesis predicts a reduction in depression severity immediately after an exercise training intervention compared with minimal change in an attention control condition, and the reduction will be maintained during a follow-up period...
April 17, 2024: BMC Neurology
https://read.qxmd.com/read/38632313/psychological-flexibility-as-a-mechanism-of-change-in-psilocybin-assisted-therapy-for-major-depression-results-from-an-exploratory-placebo-controlled-trial
#18
JOURNAL ARTICLE
Jordan Sloshower, Richard J Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D'Souza
Several phase II studies have demonstrated that psilocybin-assisted therapy shows therapeutic potential across a spectrum of neuropsychiatric conditions, including major depressive disorder (MDD). However, the mechanisms underlying its often persisting beneficial effects remain unclear. Observational research suggests that improvements in psychological flexibility may mediate therapeutic effects. However, no psychedelic trials to date have substantiated this finding in a clinical sample. In an exploratory placebo-controlled, within-subject, fixed-order study, individuals with moderate to severe MDD were administered placebo (n = 19) followed by psilocybin (0...
April 17, 2024: Scientific Reports
https://read.qxmd.com/read/38631323/serum-levels-of-the-steroid-hormone-dehydroepiandrosterone-dhea-are-associated-with-psychological-trauma-and-lymphocyte-telomere-integrity-in-women-suffering-from-depression
#19
JOURNAL ARTICLE
Karin de Punder, Juan Salinas-Manrique, Detlef E Dietrich, Alexander Karabatsiakis
INTRODUCTION: Emerging studies highlight the telomere system as an aging mechanism underlying the association between exposure to psychological trauma and the development of a wide range of physical and mental disorders, including major depressive disorder (MDD). Here, we investigated associations of circulating levels of the steroid hormone dehydroepiandrosterone (DHEA) with immune cell telomere length (TL) in the context of lifetime trauma exposure and MDD. METHODS: Lifetime traumatic events (trauma load) were assessed using the Essener Trauma Inventory (ETI) in n=22 postmenopausal female inpatients with MDD and n=22 non-depressed controls...
April 17, 2024: Neuroimmunomodulation
https://read.qxmd.com/read/38630486/prevalence-of-mental-health-disorders-among-individuals-experiencing-homelessness-a-systematic-review-and-meta-analysis
#20
JOURNAL ARTICLE
Rebecca Barry, Jennifer Anderson, Lan Tran, Anees Bahji, Gina Dimitropoulos, S Monty Ghosh, Julia Kirkham, Geoffrey Messier, Scott B Patten, Katherine Rittenbach, Dallas Seitz
IMPORTANCE: Several factors may place people with mental health disorders, including substance use disorders, at increased risk of experiencing homelessness and experiencing homelessness may also increase the risk of developing mental health disorders. Meta-analyses examining the prevalence of mental health disorders among people experiencing homelessness globally are lacking. OBJECTIVE: To determine the current and lifetime prevalence of mental health disorders among people experiencing homelessness and identify associated factors...
April 17, 2024: JAMA Psychiatry
keyword
keyword
93692
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.